In India, Zaynich will be positioned as a third-line treatment, primarily for ICU patients when other antibiotics have failed
Popular Posts
-
Indian benchmark indices, the Sensex and Nifty, staged a significant recovery on Thursday, snapping a two-day losing streak.
-
The idea behind the proposed changes to IBC regulations is to bring more transparency and procedural fairness to corporate insolvency resol...
